CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Kalyra Pharmaceuticals
Kalyra Pharmaceuticals

Kalyra Pharmaceuticals

US-based Kalyra Pharmaceuticals, founded in 2012, specializes in wholesale distribution of various drugs.

Escondido, CA, US🇺🇸
Founded
2012
Overview
Compare
Fundraising
Employees

Kalyra Pharmaceuticals, founded in 2012 and based in San Diego, specializes in the wholesale distribution of prescription and proprietary drugs. The company's core mission is to provide high-quality pharmaceutical products to healthcare providers and retailers, ensuring accessibility and reliability in the drug supply chain.

Kalyra Pharmaceuticals has made significant strides in the pharmaceutical distribution market, establishing a strong presence and reputation for quality and dependability. The company's impact is evident in its ability to consistently meet the needs of its clients, contributing to improved healthcare outcomes.

Kalyra Pharmaceuticals - Similar Companies

A&G Pharmaceutical logo

A&G Pharmaceutical

Leading Pharma logo

Leading Pharma

leadingpharma.com

Kavalia logo

Kavalia

Masters Pharmaceutical logo

Kalyra Pharmaceuticals - Quick Facts

Who are Kalyra Pharmaceuticals' competitors?

Companies similar to Kalyra Pharmaceuticals include A&G Pharmaceutical, Leading Pharma, Kavalia and Masters Pharmaceutical.

When was Kalyra Pharmaceuticals founded?

Kalyra Pharmaceuticals was founded in 2012.

Where is Kalyra Pharmaceuticals' headquarters located?

Kalyra Pharmaceuticals' headquarters is located in Escondido, CA, US.

When was Kalyra Pharmaceuticals' last funding round?

Kalyra Pharmaceuticals' most recent funding round was for $6.2M (USD) in August 2013.

How much disclosed funding has Kalyra Pharmaceuticals raised?

Kalyra Pharmaceuticals - Classification

Ownership
  • Private
Geographic Exposure
  • United States
Revenue
  • Transactional

As of Aug 21, 2013, Kalyra Pharmaceuticals has disclosed funding of $6.2M (USD). Undisclosed round amounts are excluded.

How many employees does Kalyra Pharmaceuticals have?

Kalyra Pharmaceuticals has 30 employees as of Feb 5, 2024.

Customer
  • Enterprise
Main Product
  • Drug Distribution
Tags
  • Distribution
  • Pharmaceutical
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC

Masters Pharmaceutical

mastersrx.com

Phoenix Pharmahandel logo

Phoenix Pharmahandel

phoenixgroup.eu

Pharmly logo

Pharmly

Tagent logo

Tagent

ImprimisRx logo

ImprimisRx

imprimisrx.com

Provell Pharmaceuticals logo

Provell Pharmaceuticals

provellpharma.com

PharmRight logo

PharmRight

Har-Kcy logo

Har-Kcy

Kalypsys logo

Kalypsys

kalypsys.com

Oryza Pharmaceuticals logo

Oryza Pharmaceuticals

oryzapharma.com

Cylene Pharmaceuticals logo

Cylene Pharmaceuticals

Apothecary Products logo

Apothecary Products

2800
Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified